Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|47|6|816-825

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 816-825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 2: Management and special groups

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 86-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 70-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effective options for the prevention and management of gastrointestinal and liver disease in the Asia–Pacific region

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 121-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐alcoholic fatty liver disease following liver transplantation: a clinical review

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 9, 2015-09 ,pp. : 728-737

John Wiley & Sons Inc

Access to resources Recommend Favorite

Common Features of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 148-158

Bentham Science Publishers

Access to resources Recommend Favorite